You are viewing: Asia Pacific AI in Precision Medicine Market analysis

The Asia Pacific AI in Precision Medicine Market was valued at $177.62 Million in 2024 and projected to reach to $776.17 Million by 2029, representing a compound annual growth rate of 27.9%. Asia Pacific is poised to become a dominant force in the global AI in Precision Medicine market, driven by favorable demographic trends, increasing healthcare expenditure, and government initiatives supporting digital health adoption.

Asia Pacific AI in Precision Medicine Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific AI in Precision Medicine Market Trends and Insights

  • Asia Pacific is emerging as a critical hub for AI-driven diagnostic and therapeutic innovation, driven by increasing healthcare digitalization, rising prevalence of chronic diseases, and substantial investments in healthcare infrastructure across the region.
  • The 27.9% compound annual growth rate reflects Asia Pacific's accelerating adoption of machine learning algorithms for genomic analysis, treatment personalization, and clinical decision support systems. Asia Pacific's growth trajectory outpaces many mature markets due to a combination of factors unique to the region.
  • Large patient populations, expanding middle-class healthcare spending, and government initiatives supporting digital health transformation are propelling Asia Pacific forward.
  • Countries within Asia Pacific are rapidly deploying AI-enabled precision medicine platforms in oncology, cardiology, and rare disease diagnosis, creating substantial opportunities for technology providers and healthcare organizations.
  • By 2029, Asia Pacific is expected to consolidate its position as a leading market for AI in precision medicine, with increasing clinical validation and regulatory approval of AI-based diagnostic tools across the region..

Key Market Statistics

  • CAGR (2024-2029) 27.9% CAGR
  • Market Size, 2024 ~USD 177.62 Million
  • Forecast, 2029 ~USD 776.17 Million
  • Geography Asia Pacific

Asia Pacific AI in Precision Medicine Market Overview

Rapid Market Expansion :

Asia Pacific's AI in Precision Medicine market is growing at 27.9% CAGR, expanding from $177.62 million in 2024 to $776.17 million by 2029, reflecting strong regional adoption of AI-driven healthcare solutions.

Healthcare Digitalization Wave :

Increasing digital transformation across Asia Pacific healthcare systems is accelerating AI integration for diagnostics, treatment planning, and patient monitoring, particularly in emerging economies.

Chronic Disease Burden :

Rising prevalence of diabetes, cardiovascular diseases, and cancer across Asia Pacific is driving demand for precision medicine solutions that leverage AI for early detection and personalized treatment strategies.

Infrastructure Investment Surge :

Substantial government and private sector investments in healthcare infrastructure, research facilities, and AI capabilities are positioning Asia Pacific as a critical innovation hub for precision medicine technologies.

Asia Pacific AI in Precision Medicine Market Dynamics

  • Countries across the region are investing heavily in AI research and development, creating a robust ecosystem for precision medicine innovation.
  • The convergence of large patient populations, rising chronic disease prevalence, and improving healthcare infrastructure creates unprecedented opportunities for AI-powered diagnostic and therapeutic solutions. The region's market growth will be further accelerated by partnerships between technology companies, healthcare providers, and research institutions.
  • Regulatory frameworks are evolving to support AI implementation, while cost-effective solutions are making precision medicine accessible to broader populations.
  • By 2029, Asia Pacific is expected to capture a significant share of global AI in Precision Medicine spending, establishing itself as a key market for vendors and investors seeking high-growth opportunities in healthcare innovation..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Analytical And Scientific Instrumentation

    Top Technologies
    • Environmental Testing
    • Gas Chromatography
    • Polymerase Chain Reaction (PCR)
    • Automated Liquid Handling Systems
    • Flow Cytometry
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Shimadzu Corporation
    • Merck KGaA

      Healthcare Analytics

      Top Technologies
      • Machine Learning
      • Natural Language Processing (NLP)
      • Blood Pressure Monitors
      • Computed Tomography (CT)
      • Magnetic Resonance Imaging (MRI)
      Top Companies
      • Oracle Corporation
      • PHILIPS HEALTHCARE
      • Siemens healthineers
      • Zensar Technologies Limited
      • EPIC SYSTEMS CORPORATION

        Key Takeaways

        • Asia Pacific's AI in Precision Medicine market will grow from $177.62M (2024) to $776.17M (2029), representing a 27.9% CAGR.
        • Asia Pacific is rapidly adopting AI-driven genomic analysis and treatment personalization across oncology, cardiology, and rare disease applications.
        • Government digital health initiatives and expanding healthcare infrastructure are key growth catalysts accelerating AI adoption throughout Asia Pacific.
        • Asia Pacific's large patient populations and rising healthcare spending position the region as a leading market for precision medicine innovation by 2029.

        AI in Precision Medicine Market Report Scope

        Report Metric Details
        Base Year 2024
        Fastest Growing Segment IMAGE ANALYSIS (Tool)
        Forecast Period 2024-2029
        Growth Rate CAGR of 30.7% from 2024 to 2029
        Largest Segment SOFTWARE (Component)
        Market Size Base Year (Billions) ~USD 0.79 (2024)
        Revenue Forecast (Billions) ~USD 3.92 (2029)
        Segments Covered Application, Type, Therapeutic Area, Component, Tool, Deployment, End User, Deployment 2022-2030

        Asia Pacific AI in Precision Medicine Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Application

        • Clinical Development
        • De Novo Drug Design
        • Diagnostic & Screening
        • Diagnostics & Screening
        • Drug Discovery
        • Drug Discovery & Development
        • Drug Optimization
        • Drug Repurposing
        • Safety
        • Therapeutics
        • Understanding Diseases

        By Type

        • Deep Learning
        • Disease Diagnosis
        • Disease Progression, Staging & Prognosis
        • Disease Screening
        • Other Machine Learning Types
        • Post Treatment Surveillance & Follow-Up
        • Reinforcement Learning
        • Risk Assessment & Patient Stratification
        • Supervised Learning
        • Therapy Monitoring
        • Therapy Selection & Planning
        • Unsupervised Learning

        By Therapeutic Area

        • Cardiology
        • Hematology
        • Infectious Diseases
        • Neurology
        • Oncology
        • Other Therapeutic Area
        • Other Therapeutic Areas
        • Rare Disease
        • Rare Diseases

        By Component

        • Services
        • Software

        By Tool

        • Computer Vision
        • Context Aware Processing
        • Context-Aware Processing
        • Context-Aware Processing & Computing
        • Image Analysis
        • Machine Learning
        • Natural Language Processing
        • Nlp
        • Other Tools

        By Deployment

        • Cloud-Based
        • Cloud-Based Model
        • Hybrid
        • Hybrid Model
        • On-Premise
        • On-Premise Model

        By End User

        • Healthcare Providers
        • Medical Device/Equipment Companies
        • Other End Users
        • Pharmaceutical & Biotechnology Companies
        • Research Centers, Academic Institutes & Government Organizations
        • Research Centers, Academic Institutes, & Government Organizations

        By Deployment 2022-2030

        • Cloud Based
        • Cloud-Based
        • Hybrid
        • On-Premise

        Target Audience

        • Healthcare Technology Vendors : AI and precision medicine solution providers need Asia Pacific market insights to identify growth opportunities, understand regional adoption barriers, and develop localized product strategies.
        • Investment & Private Equity Firms : Investors seeking high-growth healthcare technology opportunities require detailed Asia Pacific market analysis to evaluate investment potential and identify promising portfolio companies.
        • Healthcare Providers & Hospital Networks : Hospital systems and healthcare organizations across Asia Pacific need market intelligence to benchmark AI adoption, evaluate vendor solutions, and plan digital transformation initiatives.
        • Pharmaceutical & Biotech Companies : Drug developers and biotech firms require Asia Pacific precision medicine market data to inform R&D strategies, identify partnership opportunities, and optimize clinical trial designs.
        • Government & Healthcare Policy Makers : Regional health authorities and policymakers need market insights to develop supportive regulatory frameworks, allocate healthcare budgets, and guide digital health infrastructure investments.

        Asia Pacific vs. other regions

        HowAsia Pacific compares to the other 3 regional blocs covered in this market.

        North America
        ~USD 1718.22 Million · 31.9% wtd CAGR ·
        Europe
        ~USD 1185.99 Million · 31.3% wtd CAGR ·
        Latin America
        ~USD 147.86 Million · 30.1% wtd CAGR ·
        Middle East & Africa
        ~USD 95.36 Million · 28.1% wtd CAGR ·

        Countries within Asia Pacific - compare and drill down

        Country2025 size (native)
        ChinaUSD 19.13 Million
        JapanUSD 13.83 Million
        IndiaUSD 5.49 Million
        Rest Of Asia PacificUSD 117.82 Million

        Country market size visualization

        China
        USD 19.13 Million
        Japan
        USD 13.83 Million
        India
        USD 5.49 Million
        Rest Of Asia Pacific
        USD 117.82 Million

        Reasons to Buy this Report

        • Regional Market Sizing & Forecasts : Obtain accurate market valuations and growth projections specific to Asia Pacific, enabling precise investment decisions and resource allocation for regional expansion strategies.
        • Country-Level Intelligence : Access granular market data for key Asia Pacific countries including China, Japan, and India, identifying high-potential markets and tailoring go-to-market strategies accordingly.
        • Competitive Landscape Analysis : Understand regional competitive dynamics, key players, and market consolidation trends specific to Asia Pacific's AI precision medicine ecosystem.
        • Growth Driver Identification : Identify region-specific factors driving market expansion including healthcare digitalization initiatives, regulatory changes, and infrastructure investments unique to Asia Pacific.
        • Strategic Partnership Opportunities : Discover collaboration and partnership opportunities with regional healthcare providers, technology firms, and research institutions accelerating AI precision medicine adoption.

        Frequently asked questions

        What is the current market size of AI in Precision Medicine in Asia Pacific?

        As of 2024, the Asia Pacific AI in Precision Medicine market is valued at $177.62 million, with expectations to reach $776.17 million by 2029.

        What is the projected growth rate for AI in Precision Medicine in Asia Pacific?

        Asia Pacific's AI in Precision Medicine market is projected to grow at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

        Which countries in Asia Pacific are leading AI precision medicine adoption?

        Asia Pacific countries with advanced healthcare infrastructure and digital health initiatives are spearheading AI precision medicine deployment, though specific country rankings vary by application and regulatory environment.

        What are the primary drivers of AI adoption in Asia Pacific precision medicine?

        Key drivers include large patient populations, rising chronic disease prevalence, government digital health initiatives, expanding healthcare spending, and increasing investments in healthcare infrastructure across Asia Pacific.

        What clinical applications are most prevalent for AI in Asia Pacific precision medicine?

        Asia Pacific is experiencing significant AI adoption in oncology, cardiology, and rare disease diagnosis, with genomic analysis and treatment personalization being primary use cases.

        RESEARCH METHODOLOGY

        The study involved significant activities to estimate the current size of the AI in precision medicine market. Exhaustive secondary research was done to collect information on the AI in precision medicine market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in precision medicine market.

        Secondary Research

        This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in precision medicine solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

        Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in precision medicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in precision medicine market.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in precision medicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

        In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Breakdown of Primary Participants:

        AI in Precision Medicine Market

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in precision medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

        • The key players in the industry and markets have been identified through extensive secondary research.
        • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
        • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
        AI in Precision Medicine Market

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        The AI in precision medicine market utilises AI technologies such as machine learning and natural language processing to analyse complicated biological and clinical data in order to provide possibly personalised healthcare solutions. It promotes applications such as drug discovery, diagnostics, predictive analytics, and tailored treatment plans by integrating genomics, proteomics, and real-world data using AI capabilities with the goal of improving patient outcomes and accelerating innovation benefits for stakeholders ranging from pharmaceutical companies and healthcare providers to researchers.

        Stakeholders

        • Transfection products manufacturing companies
        • Pharmaceutical & Biopharmaceutical Companies
        • Chemical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Contract Development and Manufacturing Organizations (CDMOs)
        • Research Institutes and Universities 
        • Venture Capitalists & Investors
        • Government Associations

        Report Objectives

        • To define, describe, and forecast the AI in precision medicine market based on application, therapeutic area, component, tools, deployment, end user, and region.
        • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
        • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
        • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
        • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
        • To profile the key players and comprehensively analyze their market sizes and core competencies.
        • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally.

        Get the Full AI in Precision Medicine Market Report

        Full forecast, segment splits, and company analysis for all AI in Precision Medicine Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status